Gemcitabine for treatment of pancreatic cancer.
D000230:Adenocarcinoma / Q000188:drug therapy* / Q000556:secondary; D003841:Deoxycytidine / Q000031:analogs & derivatives* / Q000627:therapeutic use / Q000633:toxicity; D006801:Humans; D010190:Pancreatic Neoplasms / Q000188:drug therapy* / Q000556:secondary; D000093542:Gemcitabine
D003841:Deoxycytidine; D000093542:Gemcitabine